Back
ALT5 Sigma Vs. Collegium Pharmaceutical Industry Stock Comparison
Buy
90
ALTS
ALT5 Sigma
Last Price:
$6.46
Seasonality Move:
12.69%
Sell
45
COLL
Collegium Pharmaceutical
Last Price:
$33.33
Seasonality Move:
-1.63%
Buy
90
ALT5 Sigma (ALTS)
is a Buy
Is ALT5 Sigma a Buy, Sell or Hold?
-
The current ALT5 Sigma [ALTS] share price is $6.47. The Score for ALTS is 90, which is 80% above its historic median score of 50, and infers lower risk than normal.
-
ALTS is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
45
Collegium Pharmaceutical (COLL)
is a Sell
Is Collegium Pharmaceutical a Buy, Sell or Hold?
-
The current Collegium Pharmaceutical [COLL] share price is $33.34. The Score for COLL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
COLL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ALTS Stock Price Chart
What is ALT5 Sigma's stock price today?
-
The ALT5 Sigma share price today is $6.47Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALTS is experiencing buying pressure, which is a positive indicator for future bullish movement.
COLL Stock Price Chart
What is Collegium Pharmaceutical's stock price today?
-
The Collegium Pharmaceutical share price today is $33.34Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and COLL is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALTS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.86 | Buy |
Relative Strength Index (14 RSI): | 81.88 | Buy |
Chaikin Money Flow: | 253282 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.05 - 5.23) | Buy |
Bollinger Bands (100): | (1.68 - 3.74) | Buy |
COLL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.27 | Sell |
Relative Strength Index (14 RSI): | 66.05 | Buy |
Chaikin Money Flow: | 1007158 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (28.9 - 30.94) | Buy |
Bollinger Bands (100): | (30.52 - 37.92) | Sell |
ALTS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.44 | Buy |
20-day SMA: | 4.45 | Buy |
50-day SMA: | 3.25 | Buy |
200-day SMA: | 2.72 | Buy |
8-day EMA: | 5.62 | Buy |
20-day EMA: | 4.66 | Buy |
50-day EMA: | 3.64 | Buy |
200-day EMA: | 2.59 | Buy |
COLL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.45 | Buy |
20-day SMA: | 29.79 | Buy |
50-day SMA: | 30.91 | Buy |
200-day SMA: | 34.47 | Sell |
8-day EMA: | 30.02 | Buy |
20-day EMA: | 29.94 | Buy |
50-day EMA: | 31.21 | Buy |
200-day EMA: | 32.94 | Buy |
ALT5 Sigma Earnings Growth & ALTS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Collegium Pharmaceutical Earnings Growth & COLL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.42 per share, and an increase next year of $0.51 per share.
ALT5 Sigma Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Collegium Pharmaceutical Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |